Taro Pharmaceutical Industries Ltd (NYSE:TARO)

143.47
Delayed Data
As of Mar 30
 +0.25 / +0.17%
Today’s Change
102.72
Today|||52-Week Range
173.00
-3.19%
Year-to-Date

Today’s Trading

Previous close143.22
Today’s open144.78
Day’s range-- - --
Volume25,076
Average volume (3 months)70,239
Market cap$6.1B
Dividend yield--
Data as of 03/30/2015

Growth & Valuation

Earnings growth (last year)+36.58%
Earnings growth (this year)+30.06%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+13.16%
P/E ratio--
Price/Sales6.47
Price/Book6.04

Competitors

 Today’s
change
Today’s
% change
OPKOPKO Health Inc+0.22+1.52%
ICPTIntercept Pharmaceut...+2.00+0.68%
AKRXAkorn Inc-0.40-0.83%
PBYIPuma Biotechnology I...+23.76+11.00%
Data as of 03/30/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$759.3M
Annual profit (last year)$360.4M
Net profit margin47.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Kal Sundaram
Chief Financial &
Accounting Officer, Group VP
Michael Kalb
Corporate headquarters
Haifa Bay, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account